Back to Search Start Over

Low-Level Expression of CD138 Marks Naturally Arising Anergic B Cells.

Authors :
Lee S
Yang JI
Lee JH
Lee HW
Kim TJ
Source :
Immune network [Immune Netw] 2022 Oct 24; Vol. 22 (6), pp. e50. Date of Electronic Publication: 2022 Oct 24 (Print Publication: 2022).
Publication Year :
2022

Abstract

Autoreactive B cells are not entirely deleted, but some remain as immunocompetent or anergic B cells. Although the persistence of autoreactive B cells as anergic cells has been shown in transgenic mouse models with the expression of B cell receptor (BCR) reactive to engineered self-antigen, the characterization of naturally occurring anergic B cells is important to identify them and understand their contribution to immune regulation or autoimmune diseases. We report here that a low-level expression of CD138 in the splenic B cells marks naturally arising anergic B cells, not plasma cells. The CD138 <superscript>int</superscript> B cells consisted of IgM <superscript>low</superscript> IgD <superscript>high</superscript> follicular (FO) B cells and transitional 3 B cells in homeostatic conditions. The CD138 <superscript>int</superscript> FO B cells showed an anergic gene expression profile shared with that of monoclonal anergic B cells expressing engineered BCRs and the gene expression profile was different from those of plasma cells, age-associated B cells, or germinal center B cells. The anergic state of the CD138 <superscript>int</superscript> FO B cells was confirmed by attenuated Ca <superscript>2+</superscript> response and failure to upregulate CD69 upon BCR engagement with anti-IgM, anti-IgD, anti-Igκ, or anti-IgG. The BCR repertoire of the CD138 <superscript>int</superscript> FO B cells was distinct from that of the CD138 <superscript>-</superscript> FO B cells and included some class-switched B cells with low-level somatic mutations. These findings demonstrate the presence of polyclonal anergic B cells in the normal mice that are characterized by low-level expression of CD138, IgM downregulation, reduced Ca <superscript>2+</superscript> and CD69 responses upon BCR engagement, and distinct BCR repertoire.<br />Competing Interests: Conflicts of Interest: The authors declare no potential conflicts of interest.<br /> (Copyright © 2022. The Korean Association of Immunologists.)

Details

Language :
English
ISSN :
1598-2629
Volume :
22
Issue :
6
Database :
MEDLINE
Journal :
Immune network
Publication Type :
Academic Journal
Accession number :
36627940
Full Text :
https://doi.org/10.4110/in.2022.22.e50